Structural mechanism of the agonist binding on human TRPC3 channel.
Saved in:
| Title: | Structural mechanism of the agonist binding on human TRPC3 channel. |
|---|---|
| Authors: | Chen Y; State Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Beijing, China.; Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China., Zang J; State Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Beijing, China., Guo W; State Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Beijing, China.; Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.; Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China., Xu J; State Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Beijing, China., Wei M; State Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Beijing, China., Quan L; State Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Beijing, China., Zhu M; Shanghai Novamab Biopharmaceuticals Co, Ltd, Shanghai, China., Zhao X; Center for Nanochemistry, Beijing Science and Engineering Center for Nanocarbons, Beijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, Beijing, China., Peng H; Center for Nanochemistry, Beijing Science and Engineering Center for Nanocarbons, Beijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, Beijing, China., Wan Y; Shanghai Novamab Biopharmaceuticals Co, Ltd, Shanghai, China., Chen L; State Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Beijing, China. chenlei2016@pku.edu.cn.; Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China. chenlei2016@pku.edu.cn.; Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China. chenlei2016@pku.edu.cn.; National Biomedical Imaging Center, Peking University, Beijing, China. chenlei2016@pku.edu.cn. |
| Source: | Nature communications [Nat Commun] 2025 Oct 22; Vol. 16 (1), pp. 9343. Date of Electronic Publication: 2025 Oct 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41125595 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Structural mechanism of the agonist binding on human TRPC3 channel. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; State Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Beijing, China.; Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Zang+J%22">Zang J</searchLink>; State Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Guo+W%22">Guo W</searchLink>; State Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Beijing, China.; Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.; Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Xu+J%22">Xu J</searchLink>; State Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wei+M%22">Wei M</searchLink>; State Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Quan+L%22">Quan L</searchLink>; State Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Zhu+M%22">Zhu M</searchLink>; Shanghai Novamab Biopharmaceuticals Co, Ltd, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zhao+X%22">Zhao X</searchLink>; Center for Nanochemistry, Beijing Science and Engineering Center for Nanocarbons, Beijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Peng+H%22">Peng H</searchLink>; Center for Nanochemistry, Beijing Science and Engineering Center for Nanocarbons, Beijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wan+Y%22">Wan Y</searchLink>; Shanghai Novamab Biopharmaceuticals Co, Ltd, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Chen+L%22">Chen L</searchLink>; State Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Beijing, China. chenlei2016@pku.edu.cn.; Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China. chenlei2016@pku.edu.cn.; Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China. chenlei2016@pku.edu.cn.; National Biomedical Imaging Center, Peking University, Beijing, China. chenlei2016@pku.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2025 Oct 22; Vol. 16 (1), pp. 9343. <i>Date of Electronic Publication: </i>2025 Oct 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41125595 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-025-64435-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 9343 Titles: – TitleFull: Structural mechanism of the agonist binding on human TRPC3 channel. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chen Y – PersonEntity: Name: NameFull: Zang J – PersonEntity: Name: NameFull: Guo W – PersonEntity: Name: NameFull: Xu J – PersonEntity: Name: NameFull: Wei M – PersonEntity: Name: NameFull: Quan L – PersonEntity: Name: NameFull: Zhu M – PersonEntity: Name: NameFull: Zhao X – PersonEntity: Name: NameFull: Peng H – PersonEntity: Name: NameFull: Wan Y – PersonEntity: Name: NameFull: Chen L IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 10 Text: 2025 Oct 22 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 16 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |